DFFVX
Price
$37.59
Change
-$0.02 (-0.05%)
Updated
Dec 26 closing price
Net Assets
14.08B
PCVAX
Price
$11.82
Change
-$0.01 (-0.08%)
Updated
Dec 26 closing price
Net Assets
250.09M
Interact to see
Advertisement

DFFVX vs PCVAX

Header iconDFFVX vs PCVAX Comparison
Open Charts DFFVX vs PCVAXBanner chart's image
DFA US Targeted Value I
Price$37.59
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets14.08B
Virtus NFJ Small-Cap Value A
Price$11.82
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets250.09M
DFFVX vs PCVAX Comparison Chart in %
View a ticker or compare two or three
VS
DFFVX vs. PCVAX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Hold and PCVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 14.1B vs. PCVAX (250M). DFFVX pays higher dividends than PCVAX: DFFVX (1.65) vs PCVAX (1.28). DFFVX was incepted earlier than PCVAX: DFFVX (26 years) vs PCVAX (29 years). PCVAX (1.24) is less costly to investors than DFFVX (0.30). PCVAX is a more actively managed with annual turnover of: 48.00 vs. DFFVX (7.00). DFFVX has a lower initial minimum investment than PCVAX: DFFVX (0) vs PCVAX (2500). DFFVX annual gain was more profitable for investors over the last year : 10.25 vs. PCVAX (-2.80). DFFVX return over 5 years is better than : 69.65 vs. PCVAX (-6.72).
DFFVXPCVAXDFFVX / PCVAX
Total Expense Ratio0.291.1725%
Annual Report Gross Expense Ratio0.301.2424%
Fund Existence26 years29 years-
Gain YTD10.992-1.253-877%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets14.1B250M5,640%
Annual Yield % from dividends1.651.28130%
Returns for 1 year10.25-2.80-367%
Returns for 3 years43.3313.60319%
Returns for 5 years69.65-6.72-1,036%
Returns for 10 years99.61-35.87-278%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PBE84.161.03
+1.24%
Invesco Biotechnology & Genome ETF
USXF58.420.16
+0.28%
iShares® ESG Advanced MSCI USA ETF
DDWWF5.65N/A
N/A
Dividend Growth Split Corp.
USOY6.60-0.03
-0.45%
Defiance Oil Enhanced Options Income ETF
NDIA29.97-0.22
-0.72%
Global X India Active ETF